FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Laimonis Laimins

Research Profile

Living Beings

Papillomaviridae

Chemicals & Drugs

Anatomy

Physiology

Genes & Molecular Sequences

Genome, Viral

Concepts & Ideas

Molecular Sequence Data

Disorders

Co-author Network

Publications

TOP 3
Vignesh Gunasekharan; Laimonis A Laimins
Human Papillomaviruses Modulate MicroRNA 145 Expression To Directly Control Genome Amplification.
Shiyuan Hong; Laimonis A Laimins
The JAK-STAT Transcriptional Regulator, STAT-5, Activates the ATM DNA Damage Pathway to Induce HPV 31 Genome Amplification upon Epithelial Differentiation.
Jennifer A Regan; Laimonis A Laimins
Viral transformation of epithelial cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Laimonis Laimins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vignesh Gunasekharan; Laimonis A Laimins
Human Papillomaviruses Modulate MicroRNA 145 Expression To Directly Control Genome Amplification.
Journal of virology 2013;87(10):6037-43.
2013: Shiyuan Hong; Laimonis A Laimins
The JAK-STAT Transcriptional Regulator, STAT-5, Activates the ATM DNA Damage Pathway to Induce HPV 31 Genome Amplification upon Epithelial Differentiation.
PLoS pathogens 2013;9(4):e1003295.
2013: Jennifer A Regan; Laimonis A Laimins
Viral transformation of epithelial cells.
Methods in molecular biology (Clifton, N.J.) 2013;945():449-65.
2012: Mary M Donaldson; Edward S Dornan; Laimonis A Laimins; Lorna J Mackintosh; Jason M Bodily; Iain M Morgan
An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment.
Journal of virology 2012;86(23):12806-15.
2012: Kenric A Gillespie; Laimonis A Laimins; Kavi P Mehta; Cary A Moody
Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers.
Journal of virology 2012;86(17):9520-6.
2012: Elizabeth E Hoskins; Mi-Ok Kim; Laimonis A Laimins; Paul F Lambert; Parinda A Mehta; Richard J Morreale; Gerard J Nuovo; Darron R Brown; Melinda Butsch Kovacic; Stella M Davies; Maura L Gillison; Jennifer M Higginbotham; Stephen P Werner; Kathryn Ann Wikenheiser-Brokamp; David P Witte; Susanne I Wells
The fanconi anemia pathway limits human papillomavirus replication.
Journal of virology 2012;86(15):8131-8.
2011: Shiyuan Hong; Kavi P Mehta; Laimonis A Laimins
Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.
Journal of virology 2011;85(18):9486-94.
2011: Amélie Fradet-Turcotte; Laimonis A Laimins; Michael Lehoux; Cary A Moody; Fanny Bergeron-Labrecque; Jacques Archambault
Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response.
Journal of virology 2011;85(17):8996-9012.
2011: Kristen K Mighty; Laimonis A Laimins
p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation.
Journal of virology 2011;85(17):8863-9.
2011: Jason M Bodily; Linda Cruz; Kavi P M Mehta; Craig Meyers; Laimonis A Laimins
The E7 open reading frame acts in cis and in trans to mediate differentiation-dependent activities in the human papillomavirus type 16 life cycle.
Journal of virology 2011;85(17):8852-62.
2011: Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.
Virology 2011;412(1):196-210.
2011: Jason M Bodily; Kavi P M Mehta; Laimonis A Laimins
Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases.
Cancer research 2011;71(3):1187-95.
2011: Jason Bodily; Laimonis A Laimins
Persistence of human papillomavirus infection: keys to malignant progression.
Trends in microbiology 2011;19(1):33-9.
2010: Amélie Fradet-Turcotte; Cary A. Moody; Laimonis A Laimins; Jacques Archambault
Nuclear export of human papillomavirus type 31 E1 is regulated by Cdk2 phosphorylation and required for viral genome maintenance.
Journal of virology 2010;84(22):11747-60.
2010: Cary A. Moody; Laimonis A Laimins
Human papillomavirus oncoproteins: pathways to transformation.
Nature reviews. Cancer 2010;10(8):550-60.
2009: Cary A. Moody; Laimonis A Laimins
Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation.
PLoS pathogens 2009;5(10):e1000605.
2009: Melanie Beglin; Marta Melar-New; Laimonis A Laimins
Human papillomaviruses and the interferon response.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2009;29(9):629-35.
2009: Mitsuhiro Nakamura; Jason M Bodily; Melanie Beglin; Satoru Kyo; Masaki Inoue; Laimonis A Laimins
Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses.
Virology 2009;387(2):442-8.
2008: Jennifer A Regan; Laimonis A Laimins
Bap31 is a novel target of the human papillomavirus E5 protein.
Journal of virology 2008;82(20):10042-51.
2008: Tonia R Wooldridge; Laimonis A Laimins
Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding.
Virology 2008;374(2):371-80.
2008: Alexandra Côté-Martin; Cary A. Moody; Amélie Fradet-Turcotte; Claudia M D'Abramo; Michael Lehoux; Simon Joubert; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.
Journal of virology 2008;82(3):1271-83.
2007: Cary A. Moody; Amelie Fradet-Turcotte; Jacques Archambault; Laimonis A Laimins
Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(49):19541-6.
2007: Christy M Hebner; Melanie Beglin; Laimonis A Laimins
Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
Journal of virology 2007;81(23):12740-7.
2007: Regina Wilson; Gordon B Ryan; Gillian L Knight; Laimonis A Laimins; Sally Roberts
The full-length E1E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression.
Virology 2007;362(2):453-60.
2007: Hélène Sénéchal; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4.
Virology 2007;358(1):10-7.
2007: Choongho Lee; Tonia R Wooldridge; Laimonis A Laimins
Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle.
Virology 2007;358(1):201-10.
2007: Patrick L Hindmarsh; Laimonis A Laimins
Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry.
Virology journal 2007;4():19.
2006: Xuezhong Cai; Gu Li; Laimonis A Laimins; Bryan R Cullen
Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication.
Journal of virology 2006;80(21):10890-3.
2006: Christy M Hebner; Regina Wilson; Janet S Rader; Miri Bidder; Laimonis A Laimins
Human papillomaviruses target the double-stranded RNA protein kinase pathway.
The Journal of general virology 2006;87(Pt 11):3183-93.
2006: Michelle S Longworth; Laimonis A Laimins
Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src.
Oncogene 2006;25(32):4495-500.
2006: Christy M Hebner; Laimonis A Laimins
Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
Reviews in medical virology 2006;16(2):83-97.
2005: Regina Wilson; Frauke Fehrmann; Laimonis A Laimins
Role of the E1--E4 protein in the differentiation-dependent life cycle of human papillomavirus type 31.
Journal of virology 2005;79(11):6732-40.
2005: Michelle S Longworth; Regina Wilson; Laimonis A Laimins
HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs.
The EMBO journal 2005;24(10):1821-30.
2005: Kathryn M. Spink; Laimonis A Laimins
Induction of the human papillomavirus type 31 late promoter requires differentiation but not DNA amplification.
Journal of virology 2005;79(8):4918-26.
2005: Regina Wilson; Laimonis A Laimins
Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose.
Methods in molecular medicine 2005;119():157-69.
2005: Frauke Fehrmann; Laimonis A Laimins
Human papillomavirus type 31 life cycle: methods for study using tissue culture models.
Methods in molecular biology (Clifton, N.J.) 2005;292():317-30.
2004: Choongho Lee; Laimonis A Laimins
Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.
Journal of virology 2004;78(22):12366-77.
2004: Michelle S Longworth; Laimonis A Laimins
Pathogenesis of human papillomaviruses in differentiating epithelia.
Microbiology and molecular biology reviews : MMBR 2004;68(2):362-72.
2004: Michelle S Longworth; Laimonis A Laimins
The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31.
Journal of virology 2004;78(7):3533-41.
2004: Stephen T Oh; Michelle S Longworth; Laimonis A Laimins
Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11.
Journal of virology 2004;78(5):2620-6.
2003: Frauke Fehrmann; Laimonis A Laimins
Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation.
Oncogene 2003;22(33):5201-7.
2003: Frauke Fehrmann; David J Klumpp; Laimonis A Laimins
Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.
Journal of virology 2003;77(5):2819-31.
2002: Yijan E Chang; Loren Del Mar Pena; Ganes C Sen; Jung K Park; Laimonis A Laimins
Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.
Journal of virology 2002;76(17):8864-74.
2002: Walter G Hubert; Laimonis A Laimins
Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Journal of virology 2002;76(5):2263-73.
2001: L M del Mar Peña; Laimonis A Laimins
Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression.
Journal of virology 2001;75(20):10005-13.
2001: Scott S Terhune; Walter G Hubert; JT Thomas; Laimonis A Laimins
Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression.
Journal of virology 2001;75(17):8147-57.
2001: JT Thomas; Stephen T Oh; Scott S Terhune; Laimonis A Laimins
Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes.
Journal of virology 2001;75(16):7564-71.
2001: Stephen T Oh; S Kyo; Laimonis A Laimins
Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
Journal of virology 2001;75(12):5559-66.
2001: Yijan E Chang; Laimonis A Laimins
Interferon-inducible genes are major targets of human papillomavirus type 31: insights from microarray analysis.
Disease markers 2001;17(3):139-42.
2000: Yijan E Chang; Laimonis A Laimins
Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31.
Journal of virology 2000;74(9):4174-82.
2000: Frank Stubenrauch; M Hummel; Thomas Iftner; Laimonis A Laimins
The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes.
Journal of virology 2000;74(3):1178-86.
1999: Frank Stubenrauch; Laimonis A Laimins
Human papillomavirus life cycle: active and latent phases.
Seminars in cancer biology 1999;9(6):379-86.
1999: Scott S Terhune; C Milcarek; Laimonis A Laimins
Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle.
Journal of virology 1999;73(9):7185-92.
1999: JT Thomas; Walter G Hubert; MN Ruesch; Laimonis A Laimins
Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(15):8449-54.
1999: David J Klumpp; Laimonis A Laimins
Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1.
Virology 1999;257(1):239-46.
1999: Walter G Hubert; T Kanaya; Laimonis A Laimins
DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal origin.
Journal of virology 1999;73(3):1835-45.
1998: MN Ruesch; Laimonis A Laimins
Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium.
Virology 1998;250(1):19-29.
1998: Frank Stubenrauch; A M Colbert; Laimonis A Laimins
Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.
Journal of virology 1998;72(10):8115-23.
1998: MN Ruesch; Frank Stubenrauch; Laimonis A Laimins
Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10.
Journal of virology 1998;72(6):5016-24.
1998: JT Thomas; Laimonis A Laimins
Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint.
Journal of virology 1998;72(2):1131-7.
1998: Frank Stubenrauch; HB Lim; Laimonis A Laimins
Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31.
Journal of virology 1998;72(2):1071-7.
1997: David J Klumpp; Frank Stubenrauch; Laimonis A Laimins
Differential effects of the splice acceptor at nucleotide 3295 of human papillomavirus type 31 on stable and transient viral replication.
Journal of virology 1997;71(11):8186-94.
1997: T Kanaya; S Kyo; Laimonis A Laimins
The 5' region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1.
Virology 1997;237(1):159-69.
1997: Mark Frattini; HB Lim; J Doorbar; Laimonis A Laimins
Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates.
Journal of virology 1997;71(9):7068-72.
1997: MN Ruesch; Laimonis A Laimins
Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
Journal of virology 1997;71(7):5570-8.
1997: Satoru Kyo; David J Klumpp; Masaki Inoue; Taro Kanaya; Laimonis A Laimins
Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells.
The Journal of general virology 1997;78 ( Pt 2)():401-11.
1997: Mark Frattini; S D Hurst; HB Lim; S Swaminathan; Laimonis A Laimins
Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein.
The EMBO journal 1997;16(2):318-31.
1996: Mark Frattini; H B Lim; Laimonis A Laimins
In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(7):3062-7.
1996: Steven R Grossman; Laimonis A Laimins
EBNA1 and E2: a new paradigm for origin-binding proteins?
Trends in microbiology 1996;4(3):87-9.
1996: M C McIntyre; MN Ruesch; Laimonis A Laimins
Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107.
Virology 1996;215(1):73-82.
1995: S Kyo; A Tam; Laimonis A Laimins
Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Virology 1995;211(1):184-97.
1995: M Hummel; H B Lim; Laimonis A Laimins
Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing.
Journal of virology 1995;69(6):3381-8.
1995: S A Comerford; SD Maika; Laimonis A Laimins; Albee Messing; H P Elsässer; Robert E Hammer
E6 and E7 expression from the HPV 18 LCR: development of genital hyperplasia and neoplasia in transgenic mice.
Oncogene 1995;10(3):587-97.
1994: Mark Frattini; Laimonis A Laimins
Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(26):12398-402.
1994: Mark Frattini; Laimonis A Laimins
The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b.
Virology 1994;204(2):799-804.
1994: M S Lechner; Laimonis A Laimins
Inhibition of p53 DNA binding by human papillomavirus E6 proteins.
Journal of virology 1994;68(7):4262-73.
1994: C Meyers; Laimonis A Laimins
In vitro systems for the study and propagation of human papillomaviruses.
Current topics in microbiology and immunology 1994;186():199-215.
1993: A J Wagner; C Meyers; Laimonis A Laimins; Nissim Hay
c-Myc induces the expression and activity of ornithine decarboxylase.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(11):879-83.
1993: M C McIntyre; Mark Frattini; Steven R Grossman; Laimonis A Laimins
Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding.
Journal of virology 1993;67(6):3142-50.
1993: K De Geest; M E Turyk; M I Hosken; J B Hudson; Laimonis A Laimins; G D Wilbanks
Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines.
Gynecologic oncology 1993;49(3):303-10.
1993: D H Mack; Jai V Vartikar; James M Pipas; Laimonis A Laimins
Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.
Nature 1993;363(6426):281-3.
1993: Laimonis A Laimins
The biology of human papillomaviruses: from warts to cancer.
Infectious agents and disease 1993;2(2):74-86.
1992: R S Hegde; Steven R Grossman; Laimonis A Laimins; Paul B Sigler
Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target.
Nature 1992;359(6395):505-12.
1992: M Hummel; J B Hudson; Laimonis A Laimins
Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.
Journal of virology 1992;66(10):6070-80.
1992: C Meyers; Mark Frattini; J B Hudson; Laimonis A Laimins
Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.
Science (New York, N.Y.) 1992;257(5072):971-3.
1992: M S Lechner; D H Mack; A B Finicle; T Crook; K H Vousden; Laimonis A Laimins
Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.
The EMBO journal 1992;11(8):3045-52.
1992: S S Prakash; Steven R Grossman; R Blake Pepinsky; Laimonis A Laimins; Elliot J Androphy
Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 trans-activator.
Genes & development 1992;6(1):105-16.
1991: M S Lechner; Laimonis A Laimins
Human epithelial cells immortalized by SV40 retain differentiation capabilities in an in vitro raft system and maintain viral DNA extrachromosomally.
Virology 1991;185(2):563-71.
1991: D H Mack; Laimonis A Laimins
A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(20):9102-6.
1991: J S Park; Janet S Rader; Tzyy-choou Wu; Laimonis A Laimins; JL Currie; Robert J Kurman; Keerti V Shah
HPV-16 viral transcripts in vulvar neoplasia: preliminary studies.
Gynecologic oncology 1991;42(3):250-5.
1991: M A Bedell; J B Hudson; Todd R Golub; M E Turyk; M Hosken; G D Wilbanks; Laimonis A Laimins
Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation.
Journal of virology 1991;65(5):2254-60.
1991: paolo monini; Steven R Grossman; B Pepinsky; Elliot J Androphy; Laimonis A Laimins
Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences.
Journal of virology 1991;65(4):2124-30.
1991: Janet S Rader; B A Rosenzweig; R Spirtas; R Padleckas; G Javaheri; L Gerardo; Laimonis A Laimins
Atypical squamous cells. A case-series study of the association between papanicolaou smear results and human papillomavirus DNA genotype.
The Journal of reproductive medicine 1991;36(4):291-7.
1991: I L Blitz; Laimonis A Laimins
The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro.
Journal of virology 1991;65(2):649-56.
1990: Janet S Rader; Todd R Golub; J B Hudson; D Patel; M A Bedell; Laimonis A Laimins
In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions.
Oncogene 1990;5(4):571-6.
1989: Steven R Grossman; Laimonis A Laimins
E6 protein of human papillomavirus type 18 binds zinc.
Oncogene 1989;4(9):1089-93.
1989: M A Bedell; K H Jones; Steven R Grossman; Laimonis A Laimins
Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells.
Journal of virology 1989;63(3):1247-55.
1989: D Gius; Laimonis A Laimins
Activation of human papillomavirus type 18 gene expression by herpes simplex virus type 1 viral transactivators and a phorbol ester.
Journal of virology 1989;63(2):555-63.
1989: Steven R Grossman; R Mora; Laimonis A Laimins
Intracellular localization and DNA-binding properties of human papillomavirus type 18 E6 protein expressed with a baculovirus vector.
Journal of virology 1989;63(1):366-74.
1988: D J McCance; R Kopan; Elaine Fuchs; Laimonis A Laimins
Human papillomavirus type 16 alters human epithelial cell differentiation in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(19):7169-73.
1988: D Gius; Steven R Grossman; M A Bedell; Laimonis A Laimins
Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18.
Journal of virology 1988;62(3):665-72.
1987: M A Bedell; K H Jones; Laimonis A Laimins
The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells.
Journal of virology 1987;61(11):3635-40.